chr22-41170489-TACCCAA-T
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PM1PM2PM4PP3PP5_Moderate
The NM_001429.4(EP300):c.4371_4376delACCCAA(p.Ile1457_Lys1459delinsMet) variant causes a disruptive inframe deletion change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_001429.4 disruptive_inframe_deletion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EP300 | NM_001429.4 | c.4371_4376delACCCAA | p.Ile1457_Lys1459delinsMet | disruptive_inframe_deletion | Exon 27 of 31 | ENST00000263253.9 | NP_001420.2 | |
EP300 | NM_001362843.2 | c.4293_4298delACCCAA | p.Ile1431_Lys1433delinsMet | disruptive_inframe_deletion | Exon 26 of 30 | NP_001349772.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency Pathogenic:1
- -
not provided Pathogenic:1
Reported in a patient in published literature with features of Rubinstein-Taybi syndrome (Fergelot et al., 2016); In-frame deletion of 3 amino acids and insertion of 1 incorrect amino acid in a non-repeat region; Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 27648933) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at